Form 8-K - Current report:
SEC Accession No. 0001683168-26-000589
Filing Date
2026-01-28
Accepted
2026-01-28 16:01:26
Documents
14
Period of Report
2026-01-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT sonoma_8k.htm   iXBRL 8-K 39540
2 CONSULTING AGREEMENT - DR. JAY BIRNBAUM sonoma_ex1001.htm EX-10.1 42627
3 NON-EMPLOYEE DIRECTOR COMP PROGRAM AND STOCK OWNERSHIP GUIDELINES sonoma_ex1002.htm EX-10.2 23567
  Complete submission text file 0001683168-26-000589.txt   287511

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE snoa-20260128.xsd EX-101.SCH 3026
5 XBRL LABEL FILE snoa-20260128_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE snoa-20260128_pre.xml EX-101.PRE 22366
16 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_8k_htm.xml XML 3195
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 26572414
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)